These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders. Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853 [TBL] [Abstract][Full Text] [Related]
24. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups. Wise CD; Bridge TP; Potkin SG; Wyatt RJ Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348 [TBL] [Abstract][Full Text] [Related]
25. Platelet MAO activity in schizophrenia and other psychiatric illnesses. Sullivan J; Stanfield CN; Dackis C Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261 [TBL] [Abstract][Full Text] [Related]
28. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome. Mann J; Thomas KM Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192 [TBL] [Abstract][Full Text] [Related]
29. Monoamine oxidase: studies of normal and psychiatric populations in a tropical environment. Sengupta N; Datta SC; Sengupta D Enzyme; 1981; 26(4):191-200. PubMed ID: 7250095 [TBL] [Abstract][Full Text] [Related]
31. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia. Baron M; Gruen R; Levitt M; Kane J Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754 [TBL] [Abstract][Full Text] [Related]
33. Platelet monoamine oxidase in a pedigree with schizophrenia: an interlaboratory project. Ask AL; Böök JA; Heyden T; Ross SB; Unge C; Wetterberg L; Eiduson S; Kobayashi K Clin Genet; 1979 Apr; 15(4):289-99. PubMed ID: 436326 [TBL] [Abstract][Full Text] [Related]
34. Demographic, biologic, and other variables affecting monoamine oxidase activity. Robinson DS; Nies A Schizophr Bull; 1980; 6(2):298-307. PubMed ID: 7375862 [TBL] [Abstract][Full Text] [Related]
35. Human platelet MAO in drug-free and medicated schizophrenic patients. Friedhoff AJ; Miller JC; Weisenfreund J Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104 [TBL] [Abstract][Full Text] [Related]
36. Plasma levels of phenylacetic acid, m- and p-hydroxyphenylacetic acid, and platelet monoamine oxidase activity in schizophrenic and other patients. Davis BA; Yu PH; Carlson K; O'Sullivan K; Boulton AA Psychiatry Res; 1982 Feb; 6(1):97-105. PubMed ID: 6120530 [TBL] [Abstract][Full Text] [Related]
37. Protein content and monoamine oxidase activity in platelets. Zeller EA; Davis JM Schizophr Bull; 1980; 6(2):267-74. PubMed ID: 7375859 [TBL] [Abstract][Full Text] [Related]
38. Poor outcome and low platelet MAO activity in chronic schizophrenia. Bierer L; Docherty JP; Young JG; Giller E; Cohen D Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867 [TBL] [Abstract][Full Text] [Related]
39. Delusional misidentification and platelet monoamine oxidase. Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616 [TBL] [Abstract][Full Text] [Related]
40. Platelet MAO activity and family history of schizophrenia. Duncavage M; Luchins DJ; Meltzer HY Psychiatry Res; 1982 Aug; 7(1):47-51. PubMed ID: 6957899 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]